Edouard Louis

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

J. Belaiche, P. Rutgeerts, S. Vermeire, 2004, Alimentary pharmacology & therapeutics.

Cytokine gene polymorphisms in inflammatory bowel disease.

M. Parkes, J. Satsangi, D. Jewell, 1996, Gut.

Profile of soluble cytokine receptors in Crohn’s disease

J. Belaiche, D. Franchimont, E. Louis, 2005, Gut.

Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases

E. Louis, Y. Beguin, C. Lechanteur, 2017, Alimentary pharmacology & therapeutics.

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

M. Daly, J. Rioux, A. Goris, 2007, Genes and Immunity.

Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.

J. Belaiche, E. Louis, C. Reenaers, 2011, Journal of Crohn's & colitis.

Development of adenocarcinoma in chronic fistula in Crohn's disease.

J. Belaiche, E. Louis, M. Meurisse, 2005, Acta gastro-enterologica Belgica.

Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled Trial.

O. Dewit, S. Chevret, G. Savoye, 2016, Journal of Crohn's & colitis.

Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease

Lau, R. Djukanović, Louis, 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Intravenous infusion of lidocaine significantly reduces propofol dose for colonoscopy: a randomised placebo‐controlled study

A. Vanhaudenhuyse, J. Brichant, J. Joris, 2018, British journal of anaesthesia.